A major change from the 25-day Artemis I mission in 2022 is the path the crew will take. Artemis II will use what NASA calls ...

As America approaches its 250th anniversary of declaring independence, NASA's Artemis II mission will carry a host of mementos that reflect the nation's long tradition of exploration, innovation, and ...

That four-mile trek could mark the first leg of Artemis II, a 10-day journey around the moon and back that will put the ...

A burst of high-energy radiation has struck Spain’s newest military communications satellite, jolting a flagship program that Madrid has promoted as a cornerstone of its secure links with deployed ...

Moon, asteroids, and low Earth orbit. From NASA’s long-anticipated Artemis 2 to China’s growing presence on the lunar surface, government and commercial players are ramping up activity at an ...

OASIS+ is a suite of six multiple-award, indefinite-delivery/indefinite-quantity contracts with a five-year base period and a five-year option term. The contract ...

SUGAR LAND, Texas--(BUSINESS WIRE)--Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to ...

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Discov. 23, 656–657; 2024). With ...

Though the "Star Trek" franchise has become one of Paramount's biggest success stories, with its shows frequently appearing among the best series to ever grace UPN and its films becoming box office ...

The General Services Administration has launched the second phase of the One Acquisition Solution for Integrated Services Plus, or OASIS+, contract program, adding five new service domains as part of ...

Building up on the previous Super Squadron test, the Seventh Air Force launched a second phase and added another squadron with 31 F-16s at Osan. The F-16s of the U.S. Air Force’s 35th Fighter Squadron ...

A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without ...